ArticleAnnals of translational medicine2024
Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease.
Rebecca L Koch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.